FDA Hearing On ‘Hemp-Derived CBD’ Today
NORML
MAY 31, 2019
Washington, DC : Today the US Food and Drug Administration is taking in-person public testimony with regard to the “manufacturing, product quality, marketing, labeling, and sale” of CBD-infused retail products. ” Currently, commercially marketed CBD-infused products are not subject to explicit federal regulations.
Let's personalize your content